ribavirin has been researched along with tilorone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ahamad, S; Branch, S; Harrelson, S; Hussain, MK; Khan, S; Saquib, M | 1 |
Galimzianov, KhM; Kovalenko, AL; Lokteva, OM; Romantsov, MG; Stepanov, AV | 1 |
1 review(s) available for ribavirin and tilorone
Article | Year |
---|---|
Primed for global coronavirus pandemic: Emerging research and clinical outcome.
Topics: Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Drug Repositioning; Humans; Pandemics; SARS-CoV-2 | 2021 |
1 trial(s) available for ribavirin and tilorone
Article | Year |
---|---|
[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections].
Topics: Acridines; Adolescent; Adult; Aged; Animals; Antiviral Agents; Dengue; Encephalomyelitis, Venezuelan Equine; Female; Hemorrhagic Fever, Crimean; Humans; Interferon Inducers; Ixodes; Male; Mice; Middle Aged; Ribavirin; Rift Valley Fever; RNA, Double-Stranded; RNA, Fungal; Tilorone; Young Adult | 2012 |
2 other study(ies) available for ribavirin and tilorone
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |